IL132998A0 - Vif-derived hiv protease inhibitors - Google Patents

Vif-derived hiv protease inhibitors

Info

Publication number
IL132998A0
IL132998A0 IL13299898A IL13299898A IL132998A0 IL 132998 A0 IL132998 A0 IL 132998A0 IL 13299898 A IL13299898 A IL 13299898A IL 13299898 A IL13299898 A IL 13299898A IL 132998 A0 IL132998 A0 IL 132998A0
Authority
IL
Israel
Prior art keywords
vif
protease inhibitors
hiv protease
derived hiv
derived
Prior art date
Application number
IL13299898A
Original Assignee
St Luke S Roosevelt Hospital
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Luke S Roosevelt Hospital, Yissum Res Dev Co filed Critical St Luke S Roosevelt Hospital
Publication of IL132998A0 publication Critical patent/IL132998A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13299898A 1997-05-20 1998-05-20 Vif-derived hiv protease inhibitors IL132998A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4720097P 1997-05-20 1997-05-20
PCT/US1998/010307 WO1998052970A1 (en) 1997-05-20 1998-05-20 Vif-derived hiv protease inhibitors

Publications (1)

Publication Number Publication Date
IL132998A0 true IL132998A0 (en) 2001-03-19

Family

ID=21947617

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13299898A IL132998A0 (en) 1997-05-20 1998-05-20 Vif-derived hiv protease inhibitors

Country Status (4)

Country Link
EP (1) EP0980388A1 (en)
AU (1) AU7689798A (en)
IL (1) IL132998A0 (en)
WO (1) WO1998052970A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780121B2 (en) * 1999-05-13 2005-03-03 Japan Science And Technology Agency Inhibitors for viral infection targeting integrase N-terminal region
ATE343591T1 (en) 2001-04-06 2006-11-15 Univ Jefferson ANTAGONIST FOR MULTIMERIZATION OF HIV-1 VIF PROTEIN
KR20080106467A (en) 2006-03-10 2008-12-05 펩트셀 리미티드 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
WO2014066382A2 (en) * 2012-10-22 2014-05-01 University Of Rochester Assay for screening of anti-viral compounds that inhibit specific interaction interfaces between cullin5 and an elonginb/ elonginc/cbf-beta/hiv-1 vif complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS256960B1 (en) * 1985-11-16 1988-04-15 Viktor Krchnak Peptides with properties of antigenic determinants and method of their production
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
DE4141970C2 (en) * 1991-12-16 1998-02-19 Charite Med Fakultaet Combination vaccine against AIDS, schistosomiasis and tuberculosis and process for its preparation
JPH08151396A (en) * 1994-11-28 1996-06-11 Teijin Ltd Hla-binding oligopeptide and immunomodulating agent containing the compound

Also Published As

Publication number Publication date
EP0980388A1 (en) 2000-02-23
WO1998052970A1 (en) 1998-11-26
AU7689798A (en) 1998-12-11
WO1998052970A9 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
ZA983843B (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
IL132088A0 (en) Protease inhibitors
IL132630A0 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
ZA988479B (en) Protease inhibitors
EP0691345A3 (en) HIV protease inhibitor combinations
AUPM982594A0 (en) HIV protease inhibitors
ZA988064B (en) Protease inhibitors
ZA984514B (en) Hiv protease inhibitor
IL132998A0 (en) Vif-derived hiv protease inhibitors
GB9815925D0 (en) HIV Intergrase inhibitors
EP0975612A4 (en) Protease inhibitors
PL335672A1 (en) Hiv protease inhibitors
GB9714320D0 (en) Hiv protease inhibitor
GB9704559D0 (en) Protease
HU0900220D0 (en) Hiv protease inhibitors
ZA983097B (en) Protease inhibitors
PH31405A (en) Hiv protease inhibitors.
GB9716884D0 (en) Formulations for an HIV protease inhibitor
AU2002301207A1 (en) Antiviral protease inhibitors
SI0774969T1 (en) Hiv protease inhibitor combination
AU4111896A (en) Hiv protease inhibitors
GB9722761D0 (en) HIV intergrase inhibitors
GB9602851D0 (en) HIV intergrase inhibitors